EUVIMEDEUVIMED entdecken
Open Access

The common VWF variant p.Y1584C: detailed pathogenic examination of an enigmatic sequence change

Pamela A Christopherson, Nathalie Tijet, Sandra L Haberichter, Veronica H Flood, Justyne Ross, Colleen Notley, Orla Rawley, Robert R Montgomery, Zimmerman Project Investigators, Paula D James, David Lillicrap

Journal of Thrombosis and Haemostasis · 2024

DOI: 10.1016/j.jtha.2023.11.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2024. Verfasst von Pamela A Christopherson und 10 weiteren Autor:innen. Beteiligte Einrichtung: Versiti, Blood Research Institute, Milwaukee, Wisconsin. Hauptthemen laut MEDLINE: von Willebrand Disease, Type 1, von Willebrand Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, Canadian Institutes of Health Research, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: As knowledge of the human genome has advanced, so too has the recognition that interpretation of the pathogenic nature of sequence variants can be challenging. The von Willebrand factor (VWF) gene exhibits a significant degree of sequence variability, and the first VWF variant associated with type 1 von Willebrand disease (VWD), c.4751 A>G, p.Y1584C, was described in 2003. However, since that time, the pathogenic nature of this variant has remained unclear, being assigned properties ranging from a risk factor to a pathogenic variant. OBJECTIVES: To provide additional evaluation on the interpretation of pathogenicity for this common VWF variant. METHODS: Fifty-eight subjects with only the p.Y1584C variant were recruited from 2 cohort studies (the Zimmerman Program and the Canadian type 1 VWD study). Clinical and laboratory phenotypes were assessed. RESULTS: The prevalence of the p.Y1584C variant in our cohorts was 23- to 27-fold higher than that in large normal population databases. Significantly more p.Y1584C subjects had an abnormal bleeding score when compared to Y1584 individuals. In comparison with a group of 35 subjects without the p.Y1584C variant, subjects with the variant had lower mean VWF:antigen and VWF:ristocetin cofactor values and significantly higher VWF propeptide/VWF:antigen ratios suggestive of enhanced clearance. CONCLUSION: Collectively, the results of this analysis suggest that p.Y1584C is likely pathogenic, however, due to influences such as incomplete penetrance, variable expressivity, and other genetic modifiers like ABO blood group, the straightforward assignment of pathogenicity to this variant is inevitably challenging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

von Willebrand Disease, Type 1von Willebrand DiseasesHumansvon Willebrand FactorCanadaPhenotype

Stichwörter der Autor:innen

PathogenicityY1584Cgenetic variantvon Willebrand diseasevon Willebrand factor

Substanzen

von Willebrand Factor

Autor:innen und Institutionen

  • Versiti, Blood Research Institute, Milwaukee, Wisconsin.
  • Department of Pathology and Molecular Medicine, Richardson Laboratory, Queen's University, Kingston, Ontario, Canada.
  • University of North Carolina, Chapel Hill, North Carolina.
  • Department of Medicine, Queen's University, Kingston, ON, Canada.
  • Department of Pathology and Molecular Medicine, Richardson Laboratory, Queen's University, Kingston, Ontario, Canada. Electronic address: david.lillicrap@queensu.ca.

Förderung

  • NHLBI NIH HHS
  • Canadian Institutes of Health Research
  • National Institutes of Health
  • NHLBI

Zitieren

APA

Christopherson, P. A., Tijet, N., Haberichter, S. L., Flood, V. H., Ross, J., Notley, C., Rawley, O., Montgomery, R. R., Zimmerman Project Investigators, James, P. D., & Lillicrap, D. (2024). The common VWF variant p.Y1584C: detailed pathogenic examination of an enigmatic sequence change. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2023.11.016

Vancouver

Christopherson PA, Tijet N, Haberichter SL, Flood VH, Ross J, Notley C, et al. The common VWF variant p.Y1584C: detailed pathogenic examination of an enigmatic sequence change. Journal of Thrombosis and Haemostasis. 2024. doi:10.1016/j.jtha.2023.11.016

BibTeX
@article{Christopherson2024,
  author = {Christopherson, Pamela A and Tijet, Nathalie and Haberichter, Sandra L and Flood, Veronica H and Ross, Justyne and Notley, Colleen and Rawley, Orla and Montgomery, Robert R and Zimmerman Project Investigators, Zimmerman Project Investigators and James, Paula D and Lillicrap, David},
  title = {The common VWF variant p.Y1584C: detailed pathogenic examination of an enigmatic sequence change},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2024},
  doi = {10.1016/j.jtha.2023.11.016}
}
Kostenlos starten →